Harvard Profs Battle Over $1.5B Antitrust Damages Estimate – Law360

By Bonnie Eslinger (June 16, 2023, 11:11 PM EDT) — A Harvard University professor emeritus testifying in a federal antitrust trial Friday over claims Gilead and Teva illegally delayed generic versions of HIV medications told a California jury that the suit’s end-payor classes were overcharged $1.5 billion — provoking Gilead to challenge that amount at cross-examination using opinions from its own Harvard expert….